Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
2.
Endocrinology ; 161(8)2020 08 01.
Article in English | MEDLINE | ID: mdl-32623449

ABSTRACT

At birth, all female mice, including those that either lack estrogen receptor α (ERα-knockout) or that express mutated forms of ERα (AF2ERKI), have a hypoplastic uterus. However, uterine growth and development that normally accompany pubertal maturation does not occur in ERα-knockout or AF2ERKI mice, indicating ERα-mediated estrogen (E2) signaling is essential for this process. Mice that lack Cyp19 (aromatase knockout, ArKO mice), an enzyme critical for E2 synthesis, are unable to make E2 and lack pubertal uterine development. A single injection of E2 into ovariectomized adult (10 weeks old) females normally results in uterine epithelial cell proliferation; however, we observe that although ERα is present in the ArKO uterine cells, no proliferative response is seen. We assessed the impact of exposing ArKO mice to E2 during pubertal and postpubertal windows and observed that E2-exposed ArKO mice acquired growth responsiveness. Analysis of differential gene expression between unexposed ArKO samples and samples from animals exhibiting the ability to mount an E2-induced uterine growth response (wild-type [WT] or E2-exposed ArKO) revealed activation of enhancer of zeste homolog 2 (EZH2) and heart- and neural crest derivatives-expressed protein 2 (HAND2) signaling and inhibition of GLI Family Zinc Finger 1 (GLI1) responses. EZH2 and HAND2 are known to inhibit uterine growth, and GLI1 is involved in Indian hedgehog signaling, which is a positive mediator of uterine response. Finally, we show that exposure of ArKO females to dietary phytoestrogens results in their acquisition of uterine growth competence. Altogether, our findings suggest that pubertal levels of endogenous and exogenous estrogens impact biological function of uterine cells later in life via ERα-dependent mechanisms.


Subject(s)
Estradiol/administration & dosage , Infertility, Female/prevention & control , Sexual Maturation/drug effects , Urogenital Abnormalities/drug therapy , Uterus/abnormalities , Uterus/drug effects , Aging/drug effects , Aging/physiology , Animals , Drug Administration Schedule , Estradiol/pharmacology , Estrogen Receptor alpha/genetics , Female , Fertility/drug effects , Fertility/genetics , Infertility, Female/genetics , Male , Mice , Mice, Knockout , Sexual Maturation/physiology , Time Factors , Urogenital Abnormalities/genetics , Urogenital Abnormalities/physiopathology , Uterus/physiology , Uterus/physiopathology
SELECTION OF CITATIONS
SEARCH DETAIL
...